Showing results (361-370 of 576) with videos related to
Sort By:
Pageof 58
Journal of Clinical Microbiology|October 7, 2005
SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacaeDóra Szabó, Robert A Bonomo, Fernanda Silveira, et al.International Journal of Antimicrobial Agents|May 9, 2022
Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpointLaurens Manning, Sarah Metcalf, Michael Dymock, et al.Journal of Clinical Microbiology|November 4, 2016
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and CommunitiesLuis Furuya-Kanamori, Thomas V Riley, David L Paterson, et al.The Journal of Antimicrobial Chemotherapy|October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trialsMyra W Popejoy, David L Paterson, Daniel Cloutier, et al.BMC Infectious Diseases|April 20, 2022
The role and diagnostic accuracy of serology for COVID-19Debasree Kundu, Priyanka Gautam, Divya Dayanand, et al.American Journal of Infection Control|July 24, 2019
Skin colonization at peripheral intravenous catheter insertion sites increases the risk of catheter colonization and infectionMd Abu Choudhury, Hanna E Sidjabat, Hosam M Zowawi, et al.Surgical Infections|January 20, 2007
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends)Grant V Bochicchio, Fernando Baquero, Po-Ren Hsueh, et al.Open Forum Infectious Diseases|April 27, 2022
Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysisYukiko Ezure, Veronica Rico, David L Paterson, et al.International Journal of Antimicrobial Agents|November 16, 2010
Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infectionsZubair A Qureshi, David L Paterson, Diana L Pakstis, et al.Mbio|April 8, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocolAkito Kawai, Christi L McElheny, Ryan K Shields, et al.Pageof 58